INVAC-1 Anti-Cancer hTERT DNA Immunotherapy

计划入组 26 人 · 首次发布于 2014 年 11 月 26 日

Study of a DNA Immunotherapy to Treat Melanoma

计划入组 35 人 · 首次发布于 2010 年 6 月 7 日

Donor-derived Cell-free DNA for Early Diagnosis of Antibody-mediated Rejection

计划入组 40 人 · 首次发布于 2021 年 5 月 21 日

cell-mediated immunotherapy

HSB-888

Electroporation-Mediated Plasmid DNA Vaccine Therapy(NCI)

DNA International Hospital

Vietnam

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY

United States

Janssen Alzheimer Immunotherapy Research & Development LLC

United States

IMUNON Secures $7 Million in Registered Direct Offering to Advance Phase 3 DNA-Mediated Immunotherapy

IMUNON's IMNN-001 Demonstrates Significant Survival Benefit in Ovarian Cancer Phase 2 Trial

IMUNON Secures Nasdaq Listing Extension to Advance Phase 3 Ovarian Cancer Immunotherapy